Locations
Palo Alto, CA, USA · Tel Aviv-Yafo, Israel
industry
Biotechnology · DeepTech · Food · Health
Size
51-200 employees
Stage
Series B
founded in
2016
Ukko is a biotech company improving the lives of millions that suffer from food allergies and disorders. The company's computational engineering platform re-designs food allergens into safe and effective therapeutics that will become best-in-class allergy therapy. Ukko is creating a comprehensive, clinically validated map of the molecular structure of food allergies, revealing critical information about the biological mechanisms that govern human-food interactions. They use the platform to create new versions of proteins that do not elicit an immune response based on this map. These proteins enable a completely new approach to treating protein-based allergies.
Something looks off?